The side effects, risks, and precautions are nearly identical
GLP-1 RAs are preferred second-line agents in patients with T2DM with established atherosclerotic cardiovascular diseases (ASCVD) in light of their demonstrated ASCVD benefit, high efficacy, low potential for hypoglycaemia and potential for weight loss
External resources PMC: Preservation of Lean Soft Tissue During GLP-1 Weight Loss American Diabetes Association: GLP-1 Therapies and Muscle Preservation For researchers serious about optimizing their GLP-1 protocols and nutrition, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocols, and a community of thousands who have navigated these exact questions about what to eat, when to eat it, and how to make every calorie count toward their goals
Patients experiencing rapid or significant weight loss on GLP-1 therapy may therefore face indirect effects on bone health
Buijs, R
Benefits of Oral Supplements Limitations of Oral Supplements Comparing Treatment Effectiveness Clinical studies demonstrate both methods effectively treat vitamin B12 deficiency when appropriately selected for individual patient needs